Yes |
The study emphasizes transparency and accessibility of research data, underscoring the importance of making individual participant data available to foster further research and understanding. Following the commitment to data sharing, the study outlines the specifics of the data availability as follows:
Upon the completion of the trial, all individual participant data collected, after undergoing a rigorous deidentification process to protect participant privacy, will be made accessible. This comprehensive approach ensures that every piece of data gathered during the trial can be utilized for further analysis, providing a rich resource for ongoing and future research endeavors.
In addition to the raw data, a suite of essential documents will be shared, including the Study Protocol, Statistical Analysis Plan, Informed Consent Form, Clinical Study Report, and the Analytic Code. These documents offer valuable insights into the study’s methodology, analysis techniques, and ethical considerations, serving as a foundation for replicating the study or conducting related research.
The availability of data is set to commence immediately following the publication of the study’s findings, without a predetermined end date. This open-ended approach facilitates ongoing access to the data, encouraging a wide range of analyses over time.
The data and accompanying documents will be accessible to any interested party, promoting an inclusive approach that allows researchers, clinicians, and other stakeholders worldwide to engage with and analyze the data for various purposes. Whether for replicating the study, conducting meta-analyses, or exploring new research questions, the breadth of accessible data supports a wide spectrum of analytical endeavors.
To access the data, a proposal can be submitted up to 36 months following the article's publication. This period offers ample time for interested parties to develop and submit their proposals for accessing the data. |
Study Protocol |
/ |
/ |